# Array Technologies, Inc.: overview

ARRY · Nasdaq · CIK 1820721 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arry.md) · [Financials](/companies/arry/financials.md) · [Filings](/companies/arry/filings.md) · [Insiders](/companies/arry/insiders.md)

Latest reported revenue: [$342.1m](/filings/0001628280-26-053517.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053517).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [231](/filings/0001820721-25-000095.md) | [275 d](/filings/0001820721-26-000008.md) | [302](/filings/0001628280-26-031453.md) | [362](/filings/0001628280-26-053517.md) | [393](/filings/0001820721-25-000095.md) | [226 d](/filings/0001820721-26-000008.md) | [223](/filings/0001628280-26-031453.md) | [342](/filings/0001628280-26-053517.md) |
| Gross margin | % | [33.8%](/filings/0001820721-25-000095.md) | [28.5% d](/filings/0001820721-26-000008.md) | [25.3%](/filings/0001628280-26-031453.md) | [26.8%](/filings/0001628280-26-053517.md) | [26.9%](/filings/0001820721-25-000095.md) | [8.6% d](/filings/0001820721-26-000008.md) | [28.2%](/filings/0001628280-26-031453.md) | [29.1%](/filings/0001628280-26-053517.md) |
| Operating margin | % | [(57.3%)](/filings/0001820721-25-000095.md) | [(51.7%) d](/filings/0001820721-26-000008.md) | [9.0%](/filings/0001628280-26-031453.md) | [12.8%](/filings/0001628280-26-053517.md) | [11.6%](/filings/0001820721-25-000095.md) | [(65.5%) d](/filings/0001820721-26-000008.md) | [3.2%](/filings/0001628280-26-031453.md) | [10.2%](/filings/0001628280-26-053517.md) |
| Net margin | % | [(61.1%)](/filings/0001820721-25-000095.md) | [(46.1%) d](/filings/0001820721-26-000008.md) | [5.5%](/filings/0001628280-26-031453.md) | [11.9%](/filings/0001628280-26-053517.md) | [8.5%](/filings/0001820721-25-000095.md) | [(64.5%) d](/filings/0001820721-26-000008.md) | [0.9%](/filings/0001628280-26-031453.md) | [7.1%](/filings/0001628280-26-053517.md) |
| Diluted EPS | $ per share | [(1.02)](/filings/0001820721-25-000095.md) | not reported | [0.02](/filings/0001628280-26-031453.md) | [0.19](/filings/0001628280-26-053517.md) | [0.12](/filings/0001820721-25-000095.md) | not reported | [(0.09)](/filings/0001628280-26-031453.md) | [0.05](/filings/0001628280-26-053517.md) |
| Free cash flow | $m | [43.9 d](/filings/0001820721-25-000095.md) | [55.9 d](/filings/0001820721-26-000008.md) | [(15.4)](/filings/0001628280-26-031453.md) | [37.2 d](/filings/0001628280-26-053517.md) | [21.9 d](/filings/0001820721-25-000095.md) | [36.2 d](/filings/0001820721-26-000008.md) | [(36.9)](/filings/0001628280-26-031453.md) | [114 d](/filings/0001628280-26-053517.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [853](/filings/0001820721-24-000011.md) | [1,638](/filings/0001820721-25-000023.md) | [1,577](/filings/0001820721-26-000008.md) | [916](/filings/0001820721-26-000008.md) | [1,284](/filings/0001820721-26-000008.md) |
| Gross margin | % | [8.0%](/filings/0001820721-24-000011.md) | [13.0%](/filings/0001820721-25-000023.md) | [26.4%](/filings/0001820721-26-000008.md) | [32.5%](/filings/0001820721-26-000008.md) | [23.2%](/filings/0001820721-26-000008.md) |
| Operating margin | % | [(2.9%)](/filings/0001820721-24-000011.md) | [(1.1%)](/filings/0001820721-25-000023.md) | [13.6%](/filings/0001820721-26-000008.md) | [(24.8%)](/filings/0001820721-26-000008.md) | [(2.3%)](/filings/0001820721-26-000008.md) |
| Net margin | % | [(5.9%)](/filings/0001820721-24-000011.md) | [0.3%](/filings/0001820721-25-000023.md) | [8.7%](/filings/0001820721-26-000008.md) | [(26.2%)](/filings/0001820721-26-000008.md) | [(4.1%)](/filings/0001820721-26-000008.md) |
| Diluted EPS | $ per share | [(0.51)](/filings/0001820721-24-000011.md) | [(0.29)](/filings/0001820721-25-000023.md) | [0.56](/filings/0001820721-26-000008.md) | [(1.95)](/filings/0001820721-26-000008.md) | [(0.73)](/filings/0001820721-26-000008.md) |
| Free cash flow | $m | [(267)](/filings/0001820721-24-000011.md) | [131](/filings/0001820721-25-000023.md) | [215](/filings/0001820721-26-000008.md) | [147](/filings/0001820721-26-000008.md) | [79.8](/filings/0001820721-26-000008.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/arry/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-03-23 | [ATI Investment Parent, LLC](/insiders/1827785.md) | 10% owner | Sale (S) | 35,475,457 | $27.23 | $966.0m | [Form 4](/filings/0000899243-21-013473.md) |
| 2020-12-07 | [ATI Investment Parent, LLC](/insiders/1827785.md) | 10% owner | Sale (S) | 36,656,250 | $33.95 | $1.24bn | [Form 4](/filings/0000899243-20-032931.md) |
| 2020-10-19 | [ATI Investment Parent, LLC](/insiders/1827785.md) | 10% owner | Sale (S) | 47,625,000 | $22.00 | $1.05bn | [Form 4](/filings/0000899243-20-028604.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $216.8m | 29,253,142 |  | Added +66,056 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $192.5m | 25,977,000 | Call | Added +7,000,000 |
| [Hill City Capital, LP](/funds/1837343.md) | 2026-06-30 | $95.5m | 12,891,300 |  | Unchanged |
| [Grantham, Mayo, Van Otterloo & Co. LLC](/funds/1352662.md) | 2026-06-30 | $88.1m | 11,890,976 |  | Added +939,034 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $85.0m | 11,472,621 |  | Added +3,671,053 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $76.6m | 10,341,255 |  | Added +10,005,767 |
| [BNP PARIBAS ASSET MANAGEMENT Holding S.A.](/funds/1520354.md) | 2026-06-30 | $70.9m | 9,572,330 |  | Reduced −32,847 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $59.2m | 7,994,828 |  | Reduced −102,708 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $55.2m | 7,443,696 |  | Added +16,527 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $50.4m | 6,806,056 |  | Added +127,991 |

## Recent filings

[All 454 filings](/companies/arry/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-31 | 16:09 ET | [8-K](/filings/0001628280-26-059584.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-059584 |
| 2026-08-20 | 15:03 ET | [8-K](/filings/0001628280-26-058225.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-058225 |
| 2026-08-05 | 17:10 ET | [10-Q](/filings/0001628280-26-053517.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053517 |
| 2026-08-05 | 16:08 ET | [8-K](/filings/0001628280-26-053342.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053342 |
| 2026-07-16 | 16:46 ET | [8-K](/filings/0001193125-26-306194.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-306194 |
| 2026-05-20 | 16:05 ET | [8-K](/filings/0001628280-26-036881.md) | 5.07 Shareholder vote results | 0001628280-26-036881 |
| 2026-05-06 | 17:16 ET | [10-Q](/filings/0001628280-26-031453.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031453 |
| 2026-05-06 | 16:13 ET | [8-K](/filings/0001628280-26-031282.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031282 |
| 2026-04-07 | 17:05 ET | [DEF 14A](/filings/0001140361-26-013682.md) | Proxy statement, period 2026-05-19 | 0001140361-26-013682 |
| 2026-03-19 | 17:27 ET | [8-K](/filings/0001193125-26-116240.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-116240 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001820721-26-000008.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8f88e985-8fbd-4c8a-ab5f-110ae2665933)

## About the filer

- CIK: 1820721
- Tickers: ARRY
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.